← Leaderboards
David Harry McDougal
Lsu Pennington Biomedical Research Ctr
$1,099,500
Attributed
$1,099,500
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $375K · FY2023–25$500K$375K$250K$125K$0
'23
'24
'25
Funding mix
By agency
NIH$1,099,500 · 1
By mechanism
R01$1,099,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Lsu Pennington Biomedical Research Ctr
Same institution · by research overlap
- Heike Muenzberg-Gruening$9,459,014
- Yanlin He$2,473,459
- Krisztian Stadler$3,387,794
- Catrine E. Tudor-Locke$3,438,786
- Corby K Martin$10,515,569
Others in their field
Other Rising Stars on “Acute”
- Taleen Hanania · Psychogenics, Inc.$9,482,040
- Gregory Sorenson · University Of Maryland Baltimore County$9,161,697
- Christopher J. Lindsell · Vanderbilt University Medical Center$8,536,327
- Michael E. Roth · Public Health Institute$8,201,777
- Jacob Sutton Coverstone · Neurovations$6,882,205
- Agustin G Yip · Albert Einstein College Of Medicine$6,090,308
Research focus
AcuteAdrenergic AgentsAlcohol ConsumptionAdipose TissueAnimal TissueAutomobile DrivingBehavior TherapyBlood GlucoseClinical ManagementAlcoholsCold TemperatureCorticotropin-Releasing Hormone ReceptorsCounterregulationDesignDiabetes MellitusDruggable TargetDyslipidemiasEfficacious TreatmentEndocrineEventExerciseExposure ToFda ApprovedGenetic
Grant awards (3)
Evaluating the role of hypoleptinemia in impaired counterregulatory responses to hypoglycemia$375,000
R01 · FY2025 · DK · contact PI
Evaluating the role of hypoleptinemia in impaired counterregulatory responses to hypoglycemia$360,000
R01 · FY2024 · DK · contact PI
Evaluating the role of hypoleptinemia in impaired counterregulatory responses to hypoglycemia$364,500
R01 · FY2023 · DK · contact PI